Novel AI-powered retina tracker detects eye disease in under one second

	Ophthalmology & Optometry
	The latest ophthalmology / optometry news from News Medical

	Novel AI-powered retina tracker detects eye disease in under one second A novel AI-powered retina tracker can analyze retinal images with near-perfect accuracy in under one second, according to a study being presented Monday at ENDO 2025, the Endocrine Society's annual meeting in San Francisco, Calif.

	Retinal organoid model advances understanding of dry age-related macular degeneration Age-related macular degeneration (AMD), classified into dry and wet types, poses a significant threat to the vision of the elderly population globally.

			Virtual eye clinics in shopping centers cut waiting times for routine appointments Innovative virtual eye clinics in shopping centres could significantly reduce waiting times for routine eye appointments, UCL-led research suggests in a first-of-its-kind study.

			New research offers hope to preserve vision in autosomal dominant optic atrophy Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or focusing, and sometimes only as a failed vision test.

			Light-activated drug discovery identifies broad-spectrum antivirals UC Santa Barbara researchers and collaborators from campus biotech spinoff Integrated Biosciences, as well as Harvard, MIT and genomics company Illumina Ventures are using optogenetics - the use of light to probe the functions of living tissue - to find compounds to help our bodies more effectively help themselves in times of physiological stress.

	Optogenetic platform enables precise discovery of anti-aging therapeutics A landmark study published in Cell has unveiled a first-of-a-kind optogenetic screening platform, developed by scientists at Integrated Biosciences, a biotechnology company integrating optogenetics, chemistry and AI to discover small molecule therapeutics for age-related diseases.

	AI and eye scans reveal better way to predict risk from short-sightedness A combination of routine eye scans and AI has created a powerful new way for measuring short-sightedness to better predict people's long-term risk of serious retinal damage, a new study suggests.

	Emerging therapies reshape the future of AMD treatment Age-related macular degeneration (AMD) remains a leading cause of vision loss globally, with significant advancements in treatment options for both dry and wet AMD.

	Senegal becomes ninth African country to eliminate trachoma The World Health Organization (WHO) has validated Senegal as having eliminated trachoma as a public health problem. Senegal becomes the ninth country in WHO's African Region to have achieved this feat.

	UC Davis researchers pioneer safer gene therapy for vision loss The UC Davis Department of Ophthalmology has received a five-year, $3.6 million grant from the National Eye Institute to explore a new way to treat vision loss using gene therapy.

Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd.,

Manchester | Sydney | Boston

Copyright © 2000-2025